BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38556071)

  • 1. Sialylated glycoproteins and sialyltransferases in digestive cancers: Mechanisms, diagnostic biomarkers, and therapeutic targets.
    Zhang SZ; Lobo A; Li PF; Zhang YF
    Crit Rev Oncol Hematol; 2024 May; 197():104330. PubMed ID: 38556071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialylation is involved in cell fate decision during development, reprogramming and cancer progression.
    Li F; Ding J
    Protein Cell; 2019 Aug; 10(8):550-565. PubMed ID: 30478534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cancer associated mucin type O-glycans using the exchange sialylation properties of mammalian sialyltransferase ST3Gal-II.
    Chandrasekaran EV; Xue J; Xia J; Locke RD; Patil SA; Neelamegham S; Matta KL
    J Proteome Res; 2012 Apr; 11(4):2609-18. PubMed ID: 22329400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialylation: an Avenue to Target Cancer Cells.
    Vajaria BN; Patel KR; Begum R; Patel PS
    Pathol Oncol Res; 2016 Jul; 22(3):443-7. PubMed ID: 26685886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues.
    Raju TS; Briggs JB; Chamow SM; Winkler ME; Jones AJ
    Biochemistry; 2001 Jul; 40(30):8868-76. PubMed ID: 11467948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic blockade of sialylation in mice with a global inhibitor of sialyltransferases.
    Macauley MS; Arlian BM; Rillahan CD; Pang PC; Bortell N; Marcondes MC; Haslam SM; Dell A; Paulson JC
    J Biol Chem; 2014 Dec; 289(51):35149-58. PubMed ID: 25368325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the CMP-Sialic Acid Donor Specificity of Two Human β-d-Galactoside Sialyltransferases (ST3Gal I and ST6Gal I) Selectively Acting on O- and N-Glycosylproteins.
    Noel M; Gilormini PA; Cogez V; Yamakawa N; Vicogne D; Lion C; Biot C; Guérardel Y; Harduin-Lepers A
    Chembiochem; 2017 Jul; 18(13):1251-1259. PubMed ID: 28395125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible sialylation: synthesis of cytidine 5'-monophospho-N-acetylneuraminic acid from cytidine 5'-monophosphate with alpha2,3-sialyl O-glycan-, glycolipid-, and macromolecule-based donors yields diverse sialylated products.
    Chandrasekaran EV; Xue J; Xia J; Locke RD; Matta KL; Neelamegham S
    Biochemistry; 2008 Jan; 47(1):320-30. PubMed ID: 18067323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sialyltransferases functions in cancers.
    Harduin-Lepers A; Krzewinski-Recchi MA; Colomb F; Foulquier F; Groux-Degroote S; Delannoy P
    Front Biosci (Elite Ed); 2012 Jan; 4(1):499-515. PubMed ID: 22201891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
    Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
    Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of glycosylation by stable co-expression of two sialylation-related enzymes on Chinese hamster ovary cells.
    Thi Sam N; Misaki R; Ohashi T; Fujiyama K
    J Biosci Bioeng; 2018 Jul; 126(1):102-110. PubMed ID: 29439861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemophilus influenzae type b strain A2 has multiple sialyltransferases involved in lipooligosaccharide sialylation.
    Jones PA; Samuels NM; Phillips NJ; Munson RS; Bozue JA; Arseneau JA; Nichols WA; Zaleski A; Gibson BW; Apicella MA
    J Biol Chem; 2002 Apr; 277(17):14598-611. PubMed ID: 11842084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Pasteurella multocida sialyltransferase displaying dual trans-sialidase activities for production of 3'-sialyl and 6'-sialyl glycans.
    Guo Y; Jers C; Meyer AS; Arnous A; Li H; Kirpekar F; Mikkelsen JD
    J Biotechnol; 2014 Jan; 170():60-7. PubMed ID: 24291191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing the α 2, 6 sialylation of glycoproteins may contribute to metastatic spread and therapeutic resistance in colorectal cancer.
    Park JJ; Lee M
    Gut Liver; 2013 Nov; 7(6):629-41. PubMed ID: 24312702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sialyltransferase inhibition and recent advances.
    Wang L; Liu Y; Wu L; Sun XL
    Biochim Biophys Acta; 2016 Jan; 1864(1):143-53. PubMed ID: 26192491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein sialylation in atherosclerosis: Lessons from mice.
    Yu L; Peng J; Mineo C
    Front Endocrinol (Lausanne); 2022; 13():953165. PubMed ID: 36157440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sialic acid metabolism as a potential therapeutic target of atherosclerosis.
    Zhang C; Chen J; Liu Y; Xu D
    Lipids Health Dis; 2019 Sep; 18(1):173. PubMed ID: 31521172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated Systems Analysis of the Murine and Human Pancreatic Cancer Glycomes Reveals a Tumor-Promoting Role for ST6GAL1.
    Kurz E; Chen S; Vucic E; Baptiste G; Loomis C; Agrawal P; Hajdu C; Bar-Sagi D; Mahal LK
    Mol Cell Proteomics; 2021; 20():100160. PubMed ID: 34634466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavage of ST6Gal I by radiation-induced BACE1 inhibits golgi-anchored ST6Gal I-mediated sialylation of integrin β1 and migration in colon cancer cells.
    Lee M; Park JJ; Ko YG; Lee YS
    Radiat Oncol; 2012 Mar; 7():47. PubMed ID: 22449099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploiting the Disialyl Galactose Activity of α2,6-Sialyltransferase from
    Pallister EG; Choo MSF; Tai JN; Leong DSZ; Tang WQ; Ng SK; Huang K; Marchesi A; Both P; Gray C; Rudd PM; Flitsch SL; Nguyen-Khuong T
    Biochemistry; 2020 Sep; 59(34):3123-3128. PubMed ID: 31580652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.